Covance Partners with RBM to Extend Biomarker Offering

According to this article in outsourcing-pharma.com Covance will outsource biomarker activities to Rules Based Medicine, which is a US based laboratory group. Demand for biomarker services and the use of biomarker analysis in clinical trials has increased dramatically, and so this couldn't come at a better time.

Before the deal took place Covance had also begun building biomarker capacity. Under the deal RBM will apply its multi-analyte profile (MAP) technologies to projects being carried out by Covance's customers.

Share this article with your social network, just click below to share now!

Share |